The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: Background: Psoriasis has been linked to metabolic syndrome and non‐alcoholic fatty liver disease (NAFLD). Data suggest that the prevalence of NAFLD is increased in patients with psoriasis. The aim of this study was to determine the prevalence and severity of NAFLD in this patient population. Aim: To determine the prevalence of both NAFLD and non‐alcoholic steatohepatitis (NASH) in patients with psoriasis. Methods: Patients between the ages of 18 and 70 years with a diagnosis of psoriasis or psoriatic arthritis and followed by either the Dermatology or Rheumatology Division within the Department of Medicine at San Antonio Military Medical Center were considered for enrollment. Each patient completed a questionnaire, underwent a thorough skin evaluation, and had a right upper quadrant ultrasound and fasting blood work. If the liver enzymes were elevated or fatty liver detected on imaging, percutaneous liver biopsy was recommended. Results: One hundred and twenty‐nine patients were enrolled and 103 completed all necessary studies. The participants were predominantly middle aged (52.7 ± 12) and overweight or obese (average BMI 30.1 ± 5.9, range: 19.8–52.5 kg/m 2). 53% (n = 54) were male while 15% (n = 15) of participants identified themselves as being a diabetic. The overall prevalence of NAFLD was 47%. The overall prevalence of NASH was 22% in those who underwent biopsy. Conclusions: Non‐alcoholic fatty liver disease is very common among our cohort of patients with psoriasis, occurring in roughly 47% of patients. The more progressive form of the disease, NASH, is found in approximately one in five patients. Health care providers should be mindful of this association given the high prevalence of both NAFLD and NASH in this cohort of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies conducted in Italy, the Netherlands, the United States and India have shown that NAFLD affects 45.2% to 47% of patients with psoriasis [16-19].”
From Drug-induced liver injury. Part I: Classification, diagnosis and treatment (2025) · cites this paper as [18]
In the citing paper
“The risk of their development is increased by nonalcoholic fatty liver disease (NAFLD), prevalence of which is higher among patients with psoriasis than in the general population.”
From Drug-induced liver injury. Part I: Classification, diagnosis and treatment (2025) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345 · cited 2×
“a nonpsoriasis control population, 8, 9, 17 the prevalence of NAFLD in our current study is in line with the previously referenced study of nonpsoriasis patients in our local population.(14)”
ResultMiele, L., Vallone, S., Cefalo, C., La Torre, G., Di Stasi, C., Vecchio, F. M., D’Agostino, M., Gabrieli, M. L., Vero, V., Biolato, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.008 · Cited by 249
Research works printed but not linked: 16
- 10.1056/NEJMra0804595 · DOI · Paper page
- 10.1111/j.1468-3083.2010.03841.x · DOI
- 10.1016/j.amjmed.2009.06.021 · DOI · Paper page
- 10.1136/annrheumdis-2011-200567 · DOI
- 10.1016/j.jaad.2012.08.015 · DOI · Paper page
- 10.1111/j.1440-0960.2012.00905.x · DOI · Paper page
- 10.1007/s00535-004-1451-5 · DOI
- 10.1016/j.jhep.2009.04.020 · DOI · Paper page
- 10.1111/j.1529-8019.2010.01310.x · DOI
- 10.1001/archdermatol.2011.119 · DOI · Paper page
- 10.1016/j.cld.2012.03.005 · DOI
- 10.1111/j.1365-2036.2011.04724.x · DOI · Paper page
- Feldman SR, 2005, Psoriasis assessment tools in clinical trials, Ann Rheum Dis, 64, ii65, 10.1136/ard.2004.031237 · DOI · Paper page
- 10.1002/hep.20701 · DOI · Paper page
- 10.1053/j.gastro.2010.09.038 · DOI · Paper page
- 10.1016/j.jaad.2013.10.044 · DOI · Paper page
Cited by
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults
Ruan, Z., Lu, T., Chen, Y., Yuan, M., Yu, H., Liu, R., & Xie, X. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.1609 · Cited by 246
Nguyen, C. T. H., Kambe, N., Yamazaki, F., Ueda-Hayakawa, I., Kishimoto, I., & Okamoto, H. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.01.005 · Cited by 25
Drug-induced liver injury. Part I: Classification, diagnosis and treatment
Kozielewicz, D. M., Stalke, P., & Skrzypek, J. (2025) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2025.148329 · Cited by 19
Metadata
- Authors
- Roberts, K. K., Cochet, A. E., Lamb, P. B., Brown, P. J., Battafarano, D. F., Brunt, E. M., & Harrison, S. A.
- Affiliations
- Division of Gastroenterology and Hepatology Department of Medicine San Antonio Military Medical Center Fort Sam Houston TX USA
- Department of Dermatology San Antonio Military Medical Center Fort Sam Houston TX USA
- Division of Rheumatology Department of Medicine San Antonio Military Medical Center Fort Sam Houston TX USA
- Department of Pathology and Immunology School of Medicine Washington University St. Louis MO USA
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2014-12-18
- Volume
- 41
- Issue
- 3
- Pages
- 293-300
- ISSN
- 0269-2813
- 1365-2036
- Cited by
- 67
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.